NCT03477812

Brief Summary

Full ambulatory polysomnography at home performed two nights in 30 healthy children and one night in 30 children with mono-symptomatic nocturnal enuresis (15 with polyuria and 15 without polyuria). The children will be aged 7-14 years of age. The sleep will be evaluated on sleep quality, number of periodic limb movements per hour, blood pressure and pulse, beat to beat variation by electrocardiography during sleep, respiration during sleep, nocturnal urine production, and enuresis episodes.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
60

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Jan 2018

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 22, 2018

Completed
14 days until next milestone

First Submitted

Initial submission to the registry

February 5, 2018

Completed
2 months until next milestone

First Posted

Study publicly available on registry

March 26, 2018

Completed
2.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2020

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2020

Completed
Last Updated

April 5, 2018

Status Verified

January 1, 2018

Enrollment Period

2.9 years

First QC Date

February 5, 2018

Last Update Submit

April 3, 2018

Conditions

Outcome Measures

Primary Outcomes (1)

  • Sleep efficiency

    Sleep efficiency will be calculated as the ratio of the total time spent asleep to the total time spent in bed

    One night of polysomnography.

Secondary Outcomes (9)

  • Periodic limb movements during sleep

    One night of polysomnography.

  • Nocturnal urine production

    One night of polysomnography.

  • Enuresis episodes

    One night of polysomnography

  • Respiratory events during sleep

    One night of polysomnography

  • Incidence of sleep disturbances

    One night of polysomnography

  • +4 more secondary outcomes

Study Arms (3)

Healthy children

Healthy children 7-14 years of age.

Device: Polysomnography (Full sleep registration)

Nocturnal enuresis with polyuria

Children with nocturnal enuresis and polyuria aged 7-14 years.

Device: Polysomnography (Full sleep registration)

Nocturnal enuresis without polyuria

Children without nocturnal enuresis and polyuria aged 7-14 years.

Device: Polysomnography (Full sleep registration)

Interventions

For the healthy children two nights of polysomnography. For the children with nocturnal enuresis one night of polysomnography.

Healthy childrenNocturnal enuresis with polyuriaNocturnal enuresis without polyuria

Eligibility Criteria

Age7 Years - 14 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17)
Sampling MethodProbability Sample
Study Population

The study population will be 30 children with mono-symptomatic nocturnal enuresis aged from 7-14 years. The group of children with nocturnal enuresis will be split in two with 15 patients with polyuria and 15 without polyuria. The control group will be 30 healthy children aged 7-14 years of age.

You may qualify if:

  • years of age
  • Normal objective evaluation including blood pressure
  • For healthy controls achieved continence both day and night before the age of 5.
  • For children with nocturnal enuresis at least 3 wet nights per week.
  • For children with enuresis clinical characteristics and at least one week of home recordings of nocturnal urine production and two days of full recording of fluid intake and urine production.

You may not qualify if:

  • Obstipation (according to ROM IV criteria)
  • Day incontinence or severe urgency
  • Insomnia or known sleep disorders such as sleep walking, heavy snoring, night terrors or abnormal circadian rhythm.
  • Present or former deceases in the urinary tract, liver or in the endocrinological system.
  • Hypertension
  • Treatment with medication at the time of the study
  • ADHD, autism or other psychiatric disorders.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Department of Pediatrics and Adolescent Medicine, Aarhus University Hospital

Aarhus, Aarhus N, 8200, Denmark

RECRUITING

Related Publications (1)

  • Pedersen MJ, Leonthin H, Mahler B, Rittig S, Jennum PJ, Kamperis K. Two nights of home polysomnography in healthy 7-14-year-old children - Feasibility and intraindividual variability. Sleep Med. 2023 Jan;101:87-92. doi: 10.1016/j.sleep.2022.10.027. Epub 2022 Oct 30.

MeSH Terms

Conditions

Nocturnal Enuresis

Interventions

Polysomnography

Condition Hierarchy (Ancestors)

EnuresisUrination DisordersUrologic DiseasesFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesMale Urogenital DiseasesBehavioral SymptomsBehaviorElimination DisordersMental Disorders

Intervention Hierarchy (Ancestors)

Monitoring, PhysiologicDiagnostic Techniques and ProceduresDiagnosis

Study Officials

  • Søren Rittig, Professor

    Aarhus University Hospital

    STUDY CHAIR

Central Study Contacts

Malthe Jessen Pedersen, Med. student

CONTACT

Konstantinos Kamperis, Ass. prof.

CONTACT

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 5, 2018

First Posted

March 26, 2018

Study Start

January 22, 2018

Primary Completion

December 31, 2020

Study Completion

December 31, 2020

Last Updated

April 5, 2018

Record last verified: 2018-01

Data Sharing

IPD Sharing
Will not share

Individual participant data is not going to be available to other researchers.

Locations